Systems pharmacology identifies drug targets for Stargardt disease–associated retinal degeneration
Open accessThe DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
A systems pharmacological approach that capitalizes on the characterization of intracellular signaling networks can transform our understanding of human diseases and lead to therapy development. Here, we applied this strategy to identify pharmacological targets for the treatment of Stargardt disease, a severe juvenile form of macular degeneration. Diverse GPCRs have previously been implicated in neuronal cell survival, and crosstalk between GPCR signaling pathways represents an unexplored avenue for pharmacological intervention. We focused on this receptor family for potential therapeutic interventions in macular disease. Complete transcriptomes of mouse and human samples were analyzed to assess the expression of GPCRs in the retina. Focusing on adrenergic (AR) and serotonin (5-HT) receptors, we found that adrenoceptor α 2C (Adra2c) and serotonin receptor 2a (Htr2a) were the most highly expressed. Using a mouse model of Stargardt disease, we found that pharmacological interventions that targeted both GPCR signaling pathways and adenylate cyclases (ACs) improved photoreceptor cell survival, preserved photoreceptor function, and attenuated the accumulation of pathological fluorescent deposits in the retina. These findings demonstrate a strategy for the identification of new drug candidates and FDA-approved drugs for the treatment of monogenic and complex diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Major Cell Populations of the Mouse Retina
Jeon, C.-J., Strettoi, E., & Masland, R. H. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-21-08936.1998 · Cited by 1,429
Yu, D.-Y., & Cringle, S. J. (2001) · Progress in Retinal and Eye Research · doi:10.1016/s1350-9462(00)00027-6 · Cited by 653
Retinal remodeling triggered by photoreceptor degenerations
Jones, B. W., Watt, C. B., Frederick, J. M., Baehr, W., Chen, C., Levine, E. M., Milam, A. H., Lavail, M. M., & Marc, R. E. (2003) · Journal of Comparative Neurology · doi:10.1002/cne.10703 · Cited by 476 · cited 1×
“Bars indicate SDs. n = 4–6 eyes per group. metabolic demands (54), high levels of excitatory neurotrans-mitters (55), highly reactive and oxygen-sensitive chromophore (46, 56), and its sparse neurotrophic factors (57).”
Phagocytosis of Retinal Rod and Cone Photoreceptors
Kevany, B. M., & Palczewski, K. (2010) · Physiology · doi:10.1152/physiol.00038.2009 · Cited by 426 · cited 1×
“…tissue is composed of postmitotic cells with a complex intercellular organization that undergo cellular renewal processes such as phagocytosis (58, 59) and autophagy (60, 61), along with direct exposure to light action (62) causing progressive degeneration that preferentially affects the macula…”
Self-citationThe bisretinoids of retinal pigment epithelium
Sparrow, J. R., Gregory-Roberts, E., Yamamoto, K., Blonska, A., Ghosh, S. K., Ueda, K., & Zhou, J. (2012) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2011.12.001 · Cited by 392 · cited 2×
“Others have postulated that condensation products of atRAL and further light exposure cause macular degeneration (46), but how atRAL actually triggers retinal degeneration is only partially understood.”
McBee, J. K., Palczewski, K., Baehr, W., & Pepperberg, D. R. (2001) · Progress in Retinal and Eye Research · doi:10.1016/s1350-9462(01)00002-7 · Cited by 366 · cited 1×
“Bars indicate SDs. n = 4–6 eyes per group. metabolic demands (54), high levels of excitatory neurotrans-mitters (55), highly reactive and oxygen-sensitive chromophore (46, 56), and its sparse neurotrophic factors (57).”
Self-citationCell survival matters: docosahexaenoic acid signaling, neuroprotection and photoreceptors
Bazan, N. G. (2006) · Trends in Neurosciences · doi:10.1016/j.tins.2006.03.005 · Cited by 353
Chemistry and Biology of Vision
Palczewski, K. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.r111.301150 · Cited by 289
Self-citationStructure of cone photoreceptors
Mustafi, D., Engel, A. H., & Palczewski, K. (2009) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2009.05.003 · Cited by 275
Self-citationInvolvement of All-trans-retinal in Acute Light-induced Retinopathy of Mice
Maeda, A., Maeda, T., Golczak, M., Chou, S., Desai, A., Hoppel, C. L., Matsuyama, S., & Palczewski, K. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m900322200 · Cited by 248 · cited 2×
“Although the Abca4 –/– mouse model fails to mimic the human disease phenotype (36, 37), simultaneous removal of RDH8, the next enzyme in this retinoid pathway (37, 38), results in double-knock-out Abca4 –/– Rdh8 –/– mice that exhibit many phenotypic changes found in patients with Stargardt disease.”
Self-citation
Cited by
Retinoids and Retinal Diseases
Kiser, P. D., & Palczewski, K. (2016) · Annual Review of Vision Science · doi:10.1146/annurev-vision-111815-114407 · Cited by 108
“Abca4−/− mice display some features associated with SGD, although the phenotypes are mild relative to the human disease.”
InfluentialSelf-citationMolecular pharmacodynamics of emixustat in protection against retinal degeneration
Zhang, J., Kiser, P. D., Badiee, M., Palczewska, G., Dong, Z., Golczak, M., Tochtrop, G. P., & Palczewski, K. (2015) · Journal of Clinical Investigation · doi:10.1172/jci80950 · Cited by 75
Self-citationA novel small molecule chaperone of rod opsin and its potential therapy for retinal degeneration
Chen, Y., Chen, Y., Jastrzebska, B., Golczak, M., Gulati, S., Tang, H., Seibel, W., Li, X., Jin, H., Han, Y., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04261-1 · Cited by 64
Self-citationNew GABA modulators protect photoreceptor cells from light-induced degeneration in mouse models
Schur, R. M., Gao, S., Yu, G., Chen, Y., Maeda, A., Palczewski, K., & Lu, Z.-R. (2018) · The FASEB Journal · doi:10.1096/fj.201701250r · Cited by 19
Self-citationMavlyutov, T. A., Li, J., Liu, X., Shen, H., Yang, H., McCurdy, C. R., Pattnaik, B., & Guo, L.-W. (2022) · Genes · doi:10.3390/genes13122386 · Cited by 7
Metadata
- Authors
- Chen, Y., Palczewska, G., Mustafi, D., Golczak, M., Dong, Z., Sawada, O., Maeda, T., Maeda, A., & Palczewski, K.
- Venue
- Journal of Clinical Investigation
- Published
- 2013-11-15
- Volume
- 123
- Issue
- 12
- Pages
- 5119-5134
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2141445855
- Cited by
- 79
- References
- 23
- FWCI
- 3.09
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Systems pharmacology identifies drug targets for Stargardt disease–associated retinal degeneration. https://app.cochat.ai/papers/10.1172/jci69076
- The paper
- Chen, Y., Palczewska, G., Mustafi, D., Golczak, M., Dong, Z., Sawada, O., Maeda, T., Maeda, A., & Palczewski, K. (2013). Systems pharmacology identifies drug targets for Stargardt disease–associated retinal degeneration. Journal of Clinical Investigation. https://doi.org/10.1172/jci69076
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.